Evidence map›Paper›PMID 38347458›Full record

ArticleBMC medical imaging2024

In vivo PET of synaptic density as potential diagnostic marker for cognitive disorders: prospective comparison with current imaging markers for neuronal dysfunction and relation to symptomatology - study protocol.

Greet Vanderlinden, Charles Carron, Rik Vandenberghe, Mathieu Vandenbulcke, Koen Van Laere

Open access · goldAbstract read
In one paragraph

Article in BMC medical imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Perspective: Emerging challenges for a future ADNI.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Greet Vanderlinden *Nuclear Medicine and Molecular Imaging, Imaging and Pathology, KU Leuven, Leuven, Belgium. greet.vanderlinden@kuleuven.be.ORCID 0000-0002-5673-4121
Charles Carron *Nuclear Medicine and Molecular Imaging, Imaging and Pathology, KU Leuven, Leuven, Belgium.
Rik VandenbergheDepartment of Neurology, University Hospitals UZ Leuven, Leuven, Belgium.
Mathieu VandenbulckeResearch Group Psychiatry, KU Leuven, Leuven, Belgium.
Koen Van LaereNuclear Medicine and Molecular Imaging, Imaging and Pathology, KU Leuven, Leuven, Belgium.
Universitair Ziekenhuis Leuven · BEKU Leuven · BEVIB-KU Leuven Center for Brain & Disease Research · BE

Funding

Stichting Alzheimer Onderzoek SAO-FRA 2021/0004
6 · The paper itself

Abstract

background

methodsIn this prospective, multimodal imaging study, 110 patients with uncertain diagnosis of cognitive impairment who are referred for DISCUSSION: The main endpoint of the study will be the comparison of the diagnostic accuracy between

Indexed as

Cognitive DysfunctionFluorodeoxyglucose F18PyridinesPyrrolidinesFluorine RadioisotopesHumansMagnetic Resonance ImagingPositron-Emission TomographyProspective StudiesFluorine RadioisotopesFluorodeoxyglucose F18PyridinesPyrrolidinesSynVesT-118F-FDG18F-SynVesT-1Cognitive impairmentDementiaDiagnosisGlucose metabolismPET-MRSynaptic density

Identifiers

PMID38347458
PMCPMC10860316
OpenAlexW4391753498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.